PCV-VG in Pediatric Laparoscopic Surgery
Effects of Pressure Controlled-volume Guarantee Ventilation on Respiratory Mechanics in Pediatric Laparoscopic Surgery
1 other identifier
interventional
75
1 country
1
Brief Summary
This Study will aim to compare the effects of Pressure Controlled Ventilation - Volume Guarantee (PCV-VG) mode with volume control ventilation (VCV) and pressure control ventilation (PCV) modes on respiratory mechanics (including the dynamic compliance, PIP, mean airway pressure, driving pressure..etc) and oxygenation in pediatric laparoscopic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2024
CompletedStudy Start
First participant enrolled
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedJuly 30, 2024
July 1, 2024
11 months
January 14, 2024
July 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Lung dynamic compliance (Cdyn)
Dynamic compliance represents pulmonary compliance during periods of gas flow, such as during active inspiration.
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
Secondary Outcomes (7)
PaO2
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
SpO2%
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
PaCO2
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
End-tidal CO2
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
Mean airway pressure
5 minutes after intubation (T1), 5 minutes after pneumoperitoneum (T2), 15 minutes after pneumoperitoneum (T3), 5 minutes after desufflation of pneumoperitoneum (T4) and 5 minutes after the operation (T5)
- +2 more secondary outcomes
Study Arms (3)
Pressure control ventilation-volume guarantee (PCV-VG) group
ACTIVE COMPARATORIn the PCV-VG group the tidal volume will be set to 8-10ml/kg and the respiratory rate will be adjusted according to oxygen saturation and end-tidal CO¬2.
Pressure control ventilation (PCV) group
ACTIVE COMPARATORIn the PCV group peak inspiratory pressure will be set to 10-15 cm H2O titrated to achieve 8-10 ml/kg and the respiratory rate will be adjusted according to oxygen saturation and end-tidal Co2
Volume control ventilation (VCV) group
ACTIVE COMPARATORIn the VCV group tidal volume will be set to 8-10 ml/kg and the respiratory rate will be adjusted according to oxygen saturation and end-tidal CO2,
Interventions
Each arm will have a different ventilation mode according to the allocation.
Eligibility Criteria
You may qualify if:
- ASA physical status I-II.
- Both sexes.
- Age: 1-8 years old.
- Scheduled for elective abdominal or urologic laparoscopic surgery.
- BMI between the 5th and 95th percentiles.
You may not qualify if:
- ASA physical status more than II.
- Pre-existing lung disease.
- Pre-operative chest infection.
- Any thoracic deformities.
- Unsatisfactory pre-operative arterial oxygen saturation or haemoglobin level.
- Patients with cardiac, hepatic, or renal diseases.
- BMI above and below the 95th and 5th percentile respectively.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Hospital
Asyut, Asyut Governorate, Egypt
Study Officials
- STUDY DIRECTOR
Hala S Abdel-Ghaffar, MD
Assiut University
- STUDY DIRECTOR
Yara H Abbas, MD
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Single blind
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
January 14, 2024
First Posted
February 7, 2024
Study Start
February 1, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
July 30, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share